Revelation Biosciences Inc.
13F holders, Q2 2025 (June 30)7holders
2new positions
2sold out
$0.76avg. 13F price*
At the end of Q2 2025, 7 institutions reported holding Revelation Biosciences Inc. in their 13F filings, unchanged from Q1 2025. 2 opened new positions and 2 sold out. The largest holders were Sabby Management, LLC ($49K), StoneX Group Inc. ($8K) and Royal Bank of Canada ($3K).
- Company
- Revelation Biosciences Inc.
- CUSIP
- 76135L606
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $57K |
| Exits | 2 | $2K |
All 13F filers, Q1 2025 → Q2 2025: 79,906 shares bought and 784 shares sold, net +79,122 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Sabby Management, LLC | 0.40% | New | 65,789 | $49K |
| StoneX Group Inc. | 0.00% | New | 10,211 | $8K |
| Royal Bank of Canada | 0.00% | Add +152.9% | 3,422 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +70.2% | 3,478 | $3K |
| UBS Group AG | 0.00% | Add +115.2% | 751 | $563 |
| Bank of America Corp. | 0.00% | Reduce -50.0% | 9 | $7 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is REVELATION BIOSCIENCES INC's weight in each manager's 13F, not the share of Revelation Biosciences Inc. the manager owns.